Table 2 General results
Admission (8.6%) | Topographical diagnosis | Aetiological diagnosis (toast) 10 | Clinical presentation | US Stenosis | Holter | TTE/TEE | Treat |
|---|---|---|---|---|---|---|---|
Persistence of clinical signs and symptoms 1 | Left H. 42% | Cardioembolic 47% | Dysphasia 13% Monoparesis 11.2% | BA 4.3% | AF 36 | Atypical akinesia 5 | LMWH 53.5% |
Clinical instability due to comorbidity 3 | Right H. 23% | Cryptogenic 35% | Facial paresis 8.1% | ICA 3.7% | AT 2 | PFO 4 | ASA 29.2% |
Symptomatic cervical stenosis 6 | V-B 18% | Atherothrombotic 7% | Dysarthria 8.1% Hemiparesis 6.2% | VA 3.1% | advanced AVB 2 | Severe MI with dilated LA 2 | clopidogrel 9.6% |
Symptomatic intracranial stenosis 3 | Imprecise 17% | Lacunar 5% | Ataxia 3.1% Diplopia 1.8% Hemianopsia 0.6% | MCA 1.8% | ABV-II 2 USVT 2 | EF < 30% 1 | triflusal 7.7% statins 10% |
Undetermined due to several causes 5% | ACA 1.2% | Severe pause 1 | IAC 1 | ACEI 1.2% ARA-II 2.5% | |||
PCA 0.6% | AF 1 |